· 供应链分析
涉及标的： $AXTI
以当前估值推动 $AXTI 的主要是机构；做空它的散户很可能会大错特错。 如果 AXT 因出口管制而下跌，整个光子业务扩张也会受影响。（例如 AXT -> IQE -> Macom/lite）而且更值得担心的是别的问题。 如果把 AXT 10 多个上游合资企业单独拆成一家纯西方商社，它从战略角度看，价值可能会比 5N 还高。 另外，营收数字有误导性，因为这些是 TTM 合同，不是新签合同。像 7n 高纯铟这类上游材料，相比去年价格已经大涨。 这条供应链是垂直整合的，所以可能会像 NAND 一样，在有限基板下出现涨价；但不同于住友，AXT 除了少数环节（比如红磷）之外几乎包揽了整条供应链。 所以它比你想的更危险。
It’s majority institutions moving $AXTI at these valuations, retail shorts might turn out terribly wrong. If AXT goes down from export controls the photonics buildout does too. (Eg. AXT -> IQE -> Macom/lite) and there are bigger problems to worry about. If you just split out AXT’s 10+ upstream JVs into one merchant Western company it would probably be worth more strategically than 5N. Also revenue numbers are misleading since these are TTM contracts, not new ones signed. All the upstream materials like 7n high purity indium has spiked immensely since last year. It’s all vertically integrated so there might be a NAND style price hike off limited substrates, but unlike Sumitomo, AXT does the entire supply chain minus a few like red phosphorus. So it’s more dangerous than you think.